183 related articles for article (PubMed ID: 17307249)
1. Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy.
Engels B; Uckert W
Mol Aspects Med; 2007 Feb; 28(1):115-42. PubMed ID: 17307249
[TBL] [Abstract][Full Text] [Related]
2. HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.
van der Veken LT; Hoogeboom M; de Paus RA; Willemze R; Falkenburg JH; Heemskerk MH
Gene Ther; 2005 Dec; 12(23):1686-95. PubMed ID: 16034453
[TBL] [Abstract][Full Text] [Related]
3. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
van der Veken LT; Hagedoorn RS; van Loenen MM; Willemze R; Falkenburg JH; Heemskerk MH
Cancer Res; 2006 Mar; 66(6):3331-7. PubMed ID: 16540688
[TBL] [Abstract][Full Text] [Related]
4. T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.
Schaft N; Lankiewicz B; Drexhage J; Berrevoets C; Moss DJ; Levitsky V; Bonneville M; Lee SP; McMichael AJ; Gratama JW; Bolhuis RL; Willemsen R; Debets R
Int Immunol; 2006 Apr; 18(4):591-601. PubMed ID: 16507598
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
6. Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells.
Sommermeyer D; Uckert W
J Immunol; 2010 Jun; 184(11):6223-31. PubMed ID: 20483785
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor gene transfer for treatment of leukemia.
Heemskerk MH; Griffioen M; Falkenburg JH
Cytotherapy; 2008; 10(2):108-15. PubMed ID: 18368589
[TBL] [Abstract][Full Text] [Related]
8. A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer.
Kieback E; Charo J; Sommermeyer D; Blankenstein T; Uckert W
Proc Natl Acad Sci U S A; 2008 Jan; 105(2):623-8. PubMed ID: 18182487
[TBL] [Abstract][Full Text] [Related]
9. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
[TBL] [Abstract][Full Text] [Related]
10. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.
Heemskerk MH; Hoogeboom M; Hagedoorn R; Kester MG; Willemze R; Falkenburg JH
J Exp Med; 2004 Apr; 199(7):885-94. PubMed ID: 15051765
[TBL] [Abstract][Full Text] [Related]
12. Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.
van Loenen MM; Hagedoorn RS; de Boer R; van Egmond EH; Falkenburg JH; Heemskerk MH
J Immunother; 2011 Mar; 34(2):165-74. PubMed ID: 21304404
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy through TCR gene transfer.
Kessels HW; Wolkers MC; van den Boom MD; van der Valk MA; Schumacher TN
Nat Immunol; 2001 Oct; 2(10):957-61. PubMed ID: 11577349
[TBL] [Abstract][Full Text] [Related]
14. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
[TBL] [Abstract][Full Text] [Related]
15. Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.
Mommaas B; van Halteren AG; Pool J; van der Veken L; Wieles B; Heemskerk MH; Goulmy E
Haematologica; 2005 Oct; 90(10):1415-21. PubMed ID: 16219579
[TBL] [Abstract][Full Text] [Related]
16. Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells.
Hiasa A; Hirayama M; Nishikawa H; Kitano S; Nukaya I; Yu SS; Mineno J; Kato I; Shiku H
Gene Ther; 2008 May; 15(9):695-9. PubMed ID: 18288212
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor gene therapy for autoimmune diseases.
Fujio K; Okamura T; Okamoto A; Yamamoto K
Ann N Y Acad Sci; 2007 Sep; 1110():222-32. PubMed ID: 17911437
[TBL] [Abstract][Full Text] [Related]
18. Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application.
Griffioen M; van Egmond HM; Barnby-Porritt H; van der Hoorn MA; Hagedoorn RS; Kester MG; Schwabe N; Willemze R; Falkenburg JH; Heemskerk MH
Haematologica; 2008 Oct; 93(10):1535-43. PubMed ID: 18768532
[TBL] [Abstract][Full Text] [Related]
19. Designer T cells by T cell receptor replacement.
Sommermeyer D; Neudorfer J; Weinhold M; Leisegang M; Engels B; Noessner E; Heemskerk MH; Charo J; Schendel DJ; Blankenstein T; Bernhard H; Uckert W
Eur J Immunol; 2006 Nov; 36(11):3052-9. PubMed ID: 17051621
[TBL] [Abstract][Full Text] [Related]
20. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function.
Zhang T; He X; Tsang TC; Harris DT
Cancer Gene Ther; 2004 Jul; 11(7):487-96. PubMed ID: 15153936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]